Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs TCOM✓SelectedUSD · TCOMGSK vs TCOM performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs TCOM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
TCOM return
+13.8%
Excess return
+38.9%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioTCOMExcessAlpha
1D-0.1%-4.1%+4.0%+0.1%
7D-5.3%-7.0%+1.7%-5.0%
30D-3.7%+3.1%-6.7%-3.8%
3M-7.3%-12.7%+5.5%-6.8%
6M-4.2%-16.6%+12.3%-3.6%
YTD+0.9%-43.7%+44.5%+3.1%
1Y+7.3%-42.0%+49.2%+9.4%
3Y+52.7%+11.0%+41.7%+52.2%
All+52.7%+13.8%+38.9%+52.2%

Cumulative growth

Daily Returns

Daily percentage return beside TCOM.

Daily Out/Under-Performance

Portfolio return minus TCOM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × TCOM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded TCOM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling